<code id='31DC552CAF'></code><style id='31DC552CAF'></style>
    • <acronym id='31DC552CAF'></acronym>
      <center id='31DC552CAF'><center id='31DC552CAF'><tfoot id='31DC552CAF'></tfoot></center><abbr id='31DC552CAF'><dir id='31DC552CAF'><tfoot id='31DC552CAF'></tfoot><noframes id='31DC552CAF'>

    • <optgroup id='31DC552CAF'><strike id='31DC552CAF'><sup id='31DC552CAF'></sup></strike><code id='31DC552CAF'></code></optgroup>
        1. <b id='31DC552CAF'><label id='31DC552CAF'><select id='31DC552CAF'><dt id='31DC552CAF'><span id='31DC552CAF'></span></dt></select></label></b><u id='31DC552CAF'></u>
          <i id='31DC552CAF'><strike id='31DC552CAF'><tt id='31DC552CAF'><pre id='31DC552CAF'></pre></tt></strike></i>

          explore

          explore

          author:comprehensive    Page View:428
          a screen displays the text "Welcome" and a small logo of Nuance Communications, which is owned by microsoft and sells a software called dax
          Nuance Image Gallery

          Microsoft on Thursday said it will launch its artificial intelligence tool for automating clinical documentation within health records software made by Epic, a move to embed the technology in health systems nationwide.

          The AI product, DAX Copilot, will automatically draft notes through Epic’s mobile application, known as Haiku, making it available for immediate review by clinicians. The tool is designed to streamline clinician note taking, a laborious process that has become a common source of complaint within health systems.

          advertisement

          DAX Copilot is already used by hundreds of hospitals and clinics, but its availability through Epic significantly expands its reach and availability to potential users. Epic is the nation’s largest seller of software used to record and analyze patient health records.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          Anavex keeps shifting the goalposts in its clinical trials
          Anavex keeps shifting the goalposts in its clinical trials

          MollyFerguson/STATAnavexLifeSciencesisinatoughspot.Theserialdissemblerofclinicaltrialresultsmightbef

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          FDA panel issues narrow recommendation for Covid vaccine booster doses

          ROBYNBECK/AFPviaGettyImagesForanarchivedversionoflivecoverageofthehearingoftheFDA’sadvisorypanel,cli